Eli Lilly made so much cash selling weight loss drugs to people who refuse to eat less that they're now shopping for entire companies like a divorced guy at Best Buy.
The obesity windfall. That's what we're calling it when Americans pay $1,000 a month to inject themselves instead of skipping the breadsticks. Lilly turned that into acquisition capital. Smart move. Take money from people desperate to lose weight without effort and use it to buy more ways to take their money later.
Elon Musk said something about GE Vernova and the stock dropped. Of course it did. The man tweets and billions evaporate. He's got the inverse Midas touch for other people's portfolios. Retail traders saw the dip and thought opportunity. They did not think about why a car salesman's opinion on industrial energy equipment might be worth less than nothing.
GE Vernova makes power generation equipment. Turbines. Grid systems. Stuff that keeps the lights on while you're refreshing your brokerage app wondering why you're down another 8%. Musk criticized something about their business model or efficiency or who knows what because parsing his tweets for actionable intel is like reading tea leaves in a truck stop bathroom.
The stock fell anyway. Because that's what happens when the world's richest reply guy has thoughts.
Lilly's out here doing actual business. Buying companies. Expanding pipelines. Using profits from one miracle drug to fund the next miracle drug that retail traders will read about in a Reddit thread six months too late.
Chart says GE Vernova's support level is wherever Elon stops talking. Lilly's chart says up and to the right as long as Americans keep eating and hating themselves for it. Neither chart matters because you're going to do the opposite of what works and blame the market when it doesn't.
Turns out the only thing obesity drugs can't fix is your portfolio's morbid addiction to losing money on headlines.
Photo by Haberdoedas on Unsplash
Leave a Comment